Ami Organics Ltd
Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.[1]
- Market Cap ₹ 9,256 Cr.
- Current Price ₹ 1,131
- High / Low ₹ 1,322 / 504
- Stock P/E 71.9
- Book Value ₹ 147
- Dividend Yield 0.13 %
- ROCE 13.5 %
- ROE 9.36 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 17.9%
Cons
- Stock is trading at 7.70 times its book value
- Promoter holding has decreased over last 3 years: -5.09%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Part of BSE Allcap BSE Healthcare BSE SmallCap Nifty Microcap 250 Nifty Total Market
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|
160 | 188 | 236 | 240 | 341 | 520 | 617 | 688 | 906 | |
137 | 158 | 193 | 198 | 259 | 415 | 493 | 580 | 724 | |
Operating Profit | 23 | 31 | 43 | 42 | 81 | 105 | 123 | 108 | 181 |
OPM % | 14% | 16% | 18% | 18% | 24% | 20% | 20% | 16% | 20% |
0 | 3 | 1 | 2 | 0 | 3 | 4 | -18 | 21 | |
Interest | 3 | 3 | 5 | 6 | 6 | 6 | 2 | 6 | 8 |
Depreciation | 1 | 2 | 3 | 4 | 4 | 10 | 12 | 15 | 22 |
Profit before tax | 19 | 28 | 37 | 35 | 72 | 91 | 112 | 69 | 173 |
Tax % | 35% | 35% | 33% | 21% | 25% | 21% | 26% | 37% | |
12 | 18 | 25 | 27 | 54 | 72 | 83 | 44 | 129 | |
EPS in Rs | 40.17 | 61.43 | 11.73 | 13.08 | 8.57 | 9.87 | 11.43 | 5.92 | 16.16 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 15% | 13% | 25% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 26% |
TTM: | 38% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 3% |
TTM: | 96% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 25% |
1 Year: | 84% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 14% |
Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 2 | 2 | 10 | 10 | 32 | 36 | 36 | 37 | 41 |
Reserves | 38 | 56 | 71 | 97 | 132 | 482 | 550 | 638 | 1,162 |
26 | 41 | 54 | 59 | 137 | 1 | 3 | 203 | 4 | |
43 | 56 | 77 | 61 | 110 | 136 | 169 | 193 | 208 | |
Total Liabilities | 109 | 155 | 212 | 228 | 410 | 655 | 759 | 1,071 | 1,415 |
14 | 15 | 58 | 62 | 161 | 178 | 222 | 357 | 351 | |
CWIP | 11 | 30 | 2 | 12 | 0 | 3 | 30 | 125 | 189 |
Investments | 15 | 21 | 28 | 28 | 33 | 33 | 33 | 68 | 69 |
68 | 89 | 124 | 126 | 216 | 440 | 474 | 521 | 806 | |
Total Assets | 109 | 155 | 212 | 228 | 410 | 655 | 759 | 1,071 | 1,415 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
29 | 10 | 22 | 27 | 27 | -10 | 56 | 101 | |
-19 | -27 | -25 | -24 | -101 | -122 | -20 | -337 | |
-7 | 14 | 3 | 0 | 72 | 140 | -14 | 235 | |
Net Cash Flow | 2 | -2 | -0 | 3 | -2 | 8 | 21 | -1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 83 | 97 | 113 | 80 | 127 | 113 | 136 | 113 |
Inventory Days | 76 | 89 | 95 | 148 | 123 | 150 | 131 | 135 |
Days Payable | 148 | 154 | 168 | 146 | 172 | 158 | 153 | 119 |
Cash Conversion Cycle | 11 | 31 | 40 | 83 | 78 | 105 | 114 | 129 |
Working Capital Days | 46 | 59 | 63 | 80 | 117 | 139 | 140 | 138 |
ROCE % | 38% | 35% | 27% | 33% | 24% | 21% | 14% |
Documents
Announcements
-
Earnings Conference Call Is Rescheduled To Be Held On Friday, May 2, 2025 At 2.30 P.M. (IST)
2d - Ami Organics reschedules Q4FY25 earnings call to May 2, 2025, at 2:30 PM IST.
-
Earnings Conference Call Scheduled To Be Held On May 2, 2025 At 3.30 P.M. IST
24 Apr - Earnings conference call scheduled for May 2, 2025, to discuss Q4 and FY25 financial results.
- Corporate Action-Board to consider Dividend 24 Apr
-
Board Meeting Intimation for Board Meeting Intimation For Approval Of The Audited Financial Results For The Fourth Quarter & Year Ended March 31, 2025 To Be Held On May 2, 2025
24 Apr - Board meeting on May 2 to approve FY25 results and recommend final dividend; trading window closed till May 4.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
24 Apr - Ami Organics confirms non-applicability of SEBI Large Corporate framework as of March 31, 2025.
Annual reports
Concalls
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Oct 2021Transcript PPT
Business Overview
AMI Organics is a manufacturer of specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic APIs and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals. It has developed and commercialized over 520 products across 50 countries, supplied to over 500 customers. [1]